FdaApplication
ANDA 215057
Identifiers
- fda_app_no: ANDA215057
Properties
| Property | Value |
|---|---|
| applicant_name | NEXUS PHARMACEUTICALS LLC |
| application_type | ANDA |
| approval_date | 2023-06-02 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NELARABINE | NELARABINE | 250MG/50ML (5MG/ML) | INJECTABLE;INTRAVENOUS |
1 product